These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 1515873)

  • 21. Large-scale preparation of human anti-third-party veto cytotoxic T lymphocytes depleted of graft-versus-host reactivity: a new source for graft facilitating cells in bone marrow transplantation.
    Aviner S; Yao X; Krauthgamer R; Gan Y; Goren-Arbel R; Klein T; Tabilio A; McMannis JD; Champlin R; Martelli MF; Bachar-Lustig E; Reisner Y
    Hum Immunol; 2005 Jun; 66(6):644-52. PubMed ID: 15993710
    [TBL] [Abstract][Full Text] [Related]  

  • 22. B7.2-/- mature dendritic cells generate T-helper 2 and regulatory T donor cells in fetal mice after in utero allogeneic bone marrow transplantation.
    Bhattacharyya S; Cowan MJ
    Biol Blood Marrow Transplant; 2005 Sep; 11(9):657-71. PubMed ID: 16125636
    [TBL] [Abstract][Full Text] [Related]  

  • 23. T cell subsets involved in lethal graft-versus-host disease directed to immunodominant minor histocompatibility antigens.
    Berger M; Wettstein PJ; Korngold R
    Transplantation; 1994 Apr; 57(7):1095-102. PubMed ID: 7909395
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modulation of graft-versus-host disease: role of regulatory T lymphocytes.
    Hess AD
    Biol Blood Marrow Transplant; 2006 Jan; 12(1 Suppl 2):13-21. PubMed ID: 16399597
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Unexpected role of TNF-alpha in graft versus host reaction (GVHR): donor-derived TNF-alpha suppresses GVHR via inhibition of IFN-gamma-dependent donor type-1 immunity.
    Yamamoto S; Tsuji T; Matsuzaki J; Zhange Y; Chamoto K; Kosaka A; Togashi Y; Sekikawa K; Sawada K; Takeshima T; Koike T; Nishimura T
    Int Immunol; 2004 Jun; 16(6):811-7. PubMed ID: 15126416
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adoptive transfer of small numbers of DX5+ cells alleviates graft-versus-host disease in a murine model of semiallogeneic bone marrow transplantation: a potential role for NKT lymphocytes.
    Margalit M; Ilan Y; Ohana M; Safadi R; Alper R; Sherman Y; Doviner V; Rabbani E; Engelhardt D; Nagler A
    Bone Marrow Transplant; 2005 Jan; 35(2):191-7. PubMed ID: 15558045
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recovery of T cell populations after acute graft-vs-host reaction.
    Hakim FT; Payne S; Shearer GM
    J Immunol; 1994 Jan; 152(1):58-64. PubMed ID: 8254206
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Kinetics of Th1 and Th2 cytokine production during the early course of acute and chronic murine graft-versus-host disease. Regulatory role of donor CD8+ T cells.
    Rus V; Svetic A; Nguyen P; Gause WC; Via CS
    J Immunol; 1995 Sep; 155(5):2396-406. PubMed ID: 7650373
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ex vivo rapamycin generates Th1/Tc1 or Th2/Tc2 Effector T cells with enhanced in vivo function and differential sensitivity to post-transplant rapamycin therapy.
    Jung U; Foley JE; Erdmann AA; Toda Y; Borenstein T; Mariotti J; Fowler DH
    Biol Blood Marrow Transplant; 2006 Sep; 12(9):905-18. PubMed ID: 16920556
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ex vivo soluble fas ligand treatment of donor cells to selectively reduce murine acute graft versus host disease.
    Georgantas RW; Bohana-Kashtan O; Civin CI
    Transplantation; 2006 Aug; 82(4):471-8. PubMed ID: 16926590
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The influence of graft-versus-host reactivity, lymphocyte depletion, and cell dose on allogeneic bone marrow engraftment.
    Glass B; Uharek L; Gaska T; Gassmann W; Löffler H; Müller-Ruchholtz W
    Bone Marrow Transplant; 1993; 12 Suppl 3():S41-7. PubMed ID: 8124257
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Acute GVHD: pathogenesis, symptomatology, stage/severity, and treatment].
    Imamura M; Miyazaki T; Kasai M
    Nihon Rinsho; 1990 Sep; 48(9):2055-60. PubMed ID: 2232210
    [No Abstract]   [Full Text] [Related]  

  • 33. Advances in GVHD: novel lymphocyte subsets and cytokine dysregulation.
    Ferrara JL
    Bone Marrow Transplant; 1992; 10 Suppl 1():10-2. PubMed ID: 1387830
    [No Abstract]   [Full Text] [Related]  

  • 34. Graft versus host tolerance in dogs across one DLA-haplotype by depletion of CD6 positive cells.
    Schumm M; Kolb HJ; Hahn J; Beisser K; Rieber P; Günther W; Büttner M; Wilmanns W; Thierfelder S
    Prog Clin Biol Res; 1992; 377():419-25. PubMed ID: 1438440
    [No Abstract]   [Full Text] [Related]  

  • 35. Animal models of acute and chronic graft-versus-host disease.
    Hakim F; Fowler DH; Shearer GM; Gress RE
    Curr Protoc Immunol; 2001 May; Chapter 4():Unit 4.3. PubMed ID: 18432794
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Graft versus host disease].
    Volc-Platzer B
    Hautarzt; 1992 Oct; 43(10):669-77. PubMed ID: 1428880
    [No Abstract]   [Full Text] [Related]  

  • 37. Cytokine dysregulation as a mechanism of graft versus host disease.
    Ferrara JL
    Curr Opin Immunol; 1993 Oct; 5(5):794-9. PubMed ID: 8240742
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Emergency problems of the graft vs host reaction (literature survey)].
    Shevelev AS
    Probl Gematol Pereliv Krovi; 1976 Apr; 21(4):35-41. PubMed ID: 16257
    [No Abstract]   [Full Text] [Related]  

  • 39. [The immunological aspects of bone marrow transplantation].
    Okulov VB; Afanas'ev BV
    Vopr Onkol; 1992; 38(4):387-96. PubMed ID: 1300731
    [No Abstract]   [Full Text] [Related]  

  • 40. The lymphocytic infiltrate in acute cutaneous allogeneic graft-versus-host reactions lacks evidence for phenotypic restriction in donor-derived cells.
    Horn TD; Haskell J
    J Cutan Pathol; 1998 Apr; 25(4):210-4. PubMed ID: 9609140
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.